Elena Fea
Impact in
- Internal Medicine top 5%
- Venous Thromboembolism Diagnosis and Management
- Oncology top 10%
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 21
- Colorectal Cancer Treatments and Studies 13
- Cancer Treatment and Pharmacology 8
- Cancer Immunotherapy and Biomarkers 8
-
- Gastric Cancer Management and Outcomes 5
- Prostate Cancer Treatment and Research 3
- Co-authors
- Cristina Granetto (15 shared papers)Marco Merlano (14 shared papers)Ornella Garrone (11 shared papers)Ida Colantonio (11 shared papers)Gianmauro Numico (11 shared papers)Marcella Occelli (11 shared papers)Nicola Silvestris (4 shared papers)Milena Gasco (5 shared papers)
In The Last Decade
Elena Fea
28 papers receiving 586 citations
Peers
Comparison fields: 5 of 57
- Internal Medicine 109
- Oncology 385
- Hepatology 65
- Pulmonary and Respiratory Medicine 182
- Cardiology and Cardiovascular Medicine 109
Countries citing papers authored by Elena Fea
This map shows the geographic impact of Elena Fea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elena Fea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elena Fea more than expected).
Fields of papers citing papers by Elena Fea
This network shows the impact of papers produced by Elena Fea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elena Fea. The network helps show where Elena Fea may publish in the future.
Co-authors
The 25 scholars most cited alongside Elena Fea, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 166 | |
| 2 | 2015 | 125 | |
| 3 | 2009 | 49 | |
| 4 | 2021 | 42 | |
| 5 | 2017 | 32 | |
| 6 | 2003 | 32 | |
| 7 | 2016 | 20 | |
| 8 | 2005 | 17 | |
| 9 | 2008 | 17 | |
| 10 | 2011 | 16 | |
| 11 | 2006 | 15 | |
| 12 | 2018 | 15 | |
| 13 | 2012 | 15 | |
| 14 | 2021 | 7 | |
| 15 | 2020 | 6 | |
| 16 | Carboplatin and weekly paclitaxel in non-small cell lung cancer patients unfit for or pretreated with chemotherapy. | 2005 | 5 |
| 17 | 2017 | 3 | |
| 18 | 2021 | 3 | |
| 19 | Phase II study of first-line treatment in metastatic colorectal cancer (MCRC) with GONO-FOLFOXIRI (Irinotecan, Oxaliplatin and Infusional 5FU/LV) plus Bevacizumab | 2008 | 3 |
| 20 | 2016 | 2 |
About Elena Fea
Elena Fea is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Cancer Research and Public Health, Environmental and Occupational Health, having authored 29 papers that have together received 602 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (13 papers), Cancer Treatment and Pharmacology (8 papers), Cancer Immunotherapy and Biomarkers (8 papers), Gastric Cancer Management and Outcomes (5 papers), Cancer, Lipids, and Metabolism (3 papers), Prostate Cancer Treatment and Research (3 papers), Immunotherapy and Immune Responses (3 papers) and Palliative Care and End-of-Life Issues (3 papers). The work is most often cited by research in Internal Medicine (109 citations), Oncology (385 citations), Hepatology (65 citations), Pulmonary and Respiratory Medicine (182 citations) and Cardiology and Cardiovascular Medicine (109 citations). Elena Fea has collaborated with scholars based in Italy, Sweden and India. Frequent co-authors include Cristina Granetto, Marco Merlano, Ornella Garrone, Ida Colantonio, Gianmauro Numico, Marcella Occelli, Nicola Silvestris, Milena Gasco, Alfredo Falcone and Fotios Loupakis. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, Cancer Chemotherapy and Pharmacology, Cancer and International Journal of Radiation Oncology*Biology*Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.